AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

Also in today’s newsletter, US regulators plan to investigate Microsoft’s cloud business, and Disney-Reliance Indian media giant says TV ‘is not dead’ ...

Justin Smith has given his Buy rating due to a combination of factors that highlight AstraZeneca’s potential amidst current challenges. Despite concerns surrounding an investigation in China, Smith ...

DCC shares have jumped 17% in the FTSE 100 index after the Dublin-based conglomerate announced plans to focus on its energy ...

The headline equity benchmarks continued their downward trend on Thursday, marking the sixth consecutive day of losses. The Nifty 50 index settled below the 23,550 mark, having reached a days high of ...

Stocks slid on Thursday as Fed Chair Jerome Powell signaled that policymakers don't need to be in a hurry to cut rates.

Merck (MRK) stock will be in focus as company inks deal worth up to $3.3B to buy licensing rights to a cancer candidate ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Merck on Thursday said it has secured an exclusive global license to develop, manufacture and commercialize LM-299, an investigational PD-1/VEGF bispecific antibody from Shanghai-based LaNova that is ...

AstraZeneca PLC Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - AZN ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

PM Narendra Modi will receive Dominica's top honour at India-CARICOM Summit in Guyana for COVID-19 aid and strong bilateral ...